- HEXO Corp (HEXO) announced that Charlie Bowman has been appointed acting President and Chief Executive Officer
- Scott Cooper is stepping down from his role as HEXO’s President and Chief Executive Officer
- Julius Ivancsits has been appointed acting Chief Financial Officer, effective May 16, 2022
- HEXO is an award-winning licensed producer of innovative products for the global cannabis market
- HEXO Corp. (HEXO) opened trading at C$0.51 per share
HEXO Corp (HEXO) announced that Charlie Bowman has been appointed acting President and Chief Executive Officer.
Mr. Bowman will move into a permanent role upon the successful completion of Health Canada’s security clearance process.
Scott Cooper is stepping down from his role as HEXO’s President and Chief Executive Officer.
“I am honoured to lead HEXO into the future,” said Charlie Bowman, HEXO’s incoming CEO. “We are entering the next phase of HEXO’s strategic growth plan by remaining laser-focused on becoming cash-flow positive, expanding our leading brands market share across Canada’s recreational market, whilst growing our international business and launching new products for Medical.”
Mr. Bowman, who previously served as HEXO’s Acting Chief Operating Officer and General Manager of HEXO USA, brings a wealth of global leadership experience spanning the past two decades. After resetting operations as Acting COO, he is well-positioned to guide HEXO towards becoming cash flow positive.
“I am pleased to welcome Charlie to his new role at HEXO. I have no doubt that his leadership and commitment to executing HEXO’s strategic plan will lead the organization into its next phase of growth,” said Executive Chairman, Mark Attanasio, “On behalf of the entire organization, I would like to thank Scott Cooper for his leadership through a very challenging period.
The company also announced the departure of Acting Chief Financial Officer Curtis Solsvig and the appointment of Julius Ivancsits as Acting Chief Financial Officer, effective May 16, 2022.
Mr. Ivancsits will move into a permanent role upon the successful completion of Health Canada’s security clearance process for key personnel, which has been initiated.
Mr. Ivancsits brings a wealth of finance leadership experience and will oversee the company’s Finance and Accounting organization. Mr. Ivancsits has international experience in manufacturing with both Private Equity and Family Office sponsors and is well versed in corporate turnarounds. Prior to joining HEXO, he served as CFO at Goba Capital, Alpha Measurement Solutions, and Be Green Packaging along with long multiple roles at CPKelco.
Mr. Solsvig will remain with the company in an advisory role through to May 31, 2022.
HEXO is an award-winning licensed producer of innovative products for the global cannabis market.
HEXO Corp. (HEXO) opened trading at C$0.51 per share.
